Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2

Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2

BackgroundVaccination has proven the potential to control the COVID-19 pandemic worldwide. Although recent evidence suggests a poor humoral response against SARS-CoV-2 in vaccinated hematological disease (HD) patients, data on vaccination in these patients is limited with the comparison of mRNA-base...

Full description

Bibliographic Details
Main Authors: Enikő Szabó, Szabolcs Modok, Benedek Rónaszéki, Anna Faragó, Nikolett Gémes, Lajos I. Nagy, László Hackler, Katalin Farkas, Patrícia Neuperger, József Á. Balog, Attila Balog, László G. Puskás, Gabor J. Szebeni
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Medicine
Subjects:
hematology diseases
SARS-CoV-2 vaccination
BBIBP-CorV
AZD1222
BNT162b2
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1176168/full

Similar Items

Similar Items